Halozyme, Inc.
Records under this name other than the patents Halozyme, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 50 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,969,998 | Compositions of Adenosine DEAMINASE-2 (ADA2), Variants Thereof and Methods of Using Same Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,584,923 | Compositions of Adenosine DEAMINASE-2 (ADA2), Variants Thereof and Methods of Using Same Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,677,062 | Hyaluronidase and Factor VIII Compositions Term ended Term ended Sep 27, 2026 · Medium confidence | Term ended | Term ended Sep 27, 2026 | Medium confidence |
| US 9,993,529 | Stable formulations of a hyaluronan-degrading enzyme Lapsed on the fee record Ended Jun 12, 2026 · High confidence | Lapsed on the fee record | Ended Jun 12, 2026 | High confidence |
| US 9,913,822 | Combination therapy with an anti-hyaluronan agent and therapeutic agent Lapsed on the fee record Ended Mar 13, 2026 · High confidence | Lapsed on the fee record | Ended Mar 13, 2026 | High confidence |
| US 9,878,046 | Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects Lapsed on the fee record Ended Jan 30, 2026 · High confidence | Lapsed on the fee record | Ended Jan 30, 2026 | High confidence |
| US 8,450,470 | Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof Term ended Term ended Sep 29, 2025 · High confidence | Term ended | Term ended Sep 29, 2025 | High confidence |
| US 8,431,124 | Methods for Treating a Disease Characterized by an Excess of Hyaluronan by Administering a Soluble Hyaluronidase Glycoprotein (SHASEGP) Term ended Term ended Aug 30, 2025 · High confidence | Term ended | Term ended Aug 30, 2025 | High confidence |
| US 7,829,081 | Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases Term ended Ended no later than Feb 23, 2025 · Medium confidence | Term ended | Ended no later than Feb 23, 2025 | Medium confidence |
| US 7,846,431 | Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases Term ended Ended no later than Feb 23, 2025 · Medium confidence | Term ended | Ended no later than Feb 23, 2025 | Medium confidence |